Schott expands Chinese glass tubing plant

Schott’s pharmaceutical glass tubing site in Jinyun, China [Image courtesy of Schott]

Schott recently announced that it has completed the next expansion stage at its pharmaceutical glass tubing site in Jinyun, China.

The company completed construction at the site in just 15 months despite the COVID-19 pandemic, with production starting in November 2020. The plant is meant to create a solid production base for high-quality borosilicate glass tubing in the local Chinese market. The tubing is for pharma containers that store vaccines (e.g., against COVID-19) and other drugs.

“Right on schedule with our planning, we have doubled our melting capacity. It’s another big milestone for pharma tubing in China. The expanded infrastructure will enable a reliable local supply of glass tubing, which is needed urgently to serve the increased demand for pharmaceutical packaging,” Patrick Marksc…

Read more
  • 0

Advanced glass diffusers bring precision light delivery to the brain

Laser interstitial thermal therapy (LITT) has proven to be a successful and efficient treatment method for various brain diseases.

Anthony Cappabianca, Schott North America

It’s possible to use LITT during minimally invasive brain surgery to kill tumor cells or disrupt lesions responsible for epileptic seizures. [Image courtesy of Schott]

Thanks to advances in imaging, lasers and light delivery technology, it is now possible to use laser light to ablate lesions in the brain without the need for a craniotomy. This emerging neurosurgical procedure, known as laser interstitial thermal therapy (LITT) or laser-thermo ablation, can kill tumor cells or disrupt lesions responsible for epileptic seizures. Because the treatment is performed through a tiny opening in the skull about 4 mm in diameter (1/8 inch), recovery time for patients is greatly reduced.

Although just two LITT systems are approved for clinical u…

Read more
  • 0